SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-249389
Filing Date
2021-08-18
Accepted
2021-08-17 18:43:31
Documents
12
Period of Report
2021-08-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d197739d8k.htm   iXBRL 8-K 39208
  Complete submission text file 0001193125-21-249389.txt   162805

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arpo-20210817.xsd EX-101.SCH 2885
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20210817_lab.xml EX-101.LAB 18122
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20210817_pre.xml EX-101.PRE 11400
5 EXTRACTED XBRL INSTANCE DOCUMENT d197739d8k_htm.xml XML 3404
Mailing Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140
Business Address 10663 LOVELAND-MADEIRA ROAD #168 LOVELAND OH 45140 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 211184498
SIC: 2834 Pharmaceutical Preparations